What is Jeuveau?
Although newer competitors, such as Dysport and Xeomin, have gained popularity in treating dynamic expression lines – wrinkles or lines that are visible when we express ourselves, such as frown lines, lines on the forehead, and crow’s feet and smile lines around the eyes – Botox remains the most popular brand. However, for the first time in nearly a decade, the FDA gave the go-ahead to a new neurotoxin – Jeuveau. “NEWTOX”, as it’s also known, is structurally identical to the others.
What Is the Difference Between Jeuveau and Botox?
Jeuveau works just like the other injectable neurotoxins – it relaxes facial muscles via a paralytic effect. Jeuveau is a botulism toxin type A, a new wrinkle-relaxing injectable that’s very similar to the other neuromodulators. It can be used in any area that Botox is used, both for cosmetic and medical reasons. Like all of the other neurotoxins, Jeuveau is FDA-approved to temporarily improve the appearance of frown lines between the eyebrows — the “11s”, but medically known as the glabellar lines. Injectors also use the neurotoxins off-label to treat other areas such as the crow’s feet and smile lines around the eyes. Jeuveau is produced from different strains of the same toxin. The risks and potential side effects listed by the companies are also identical.